[Substance abuse and cardiovascular risk: cocaine].

Sostanze d’abuso e rischio cardiovascolare: la cocaina.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Jun 2022
Historique:
entrez: 8 6 2022
pubmed: 9 6 2022
medline: 10 6 2022
Statut: ppublish

Résumé

Cocaine abuse is widely increasing, especially in younger individuals. Cocaine is a major cause of chest pain and acute coronary syndrome and is the leading cause for drug abuse-related visits to emergency departments, most of which are due to cardiovascular complaints. Cocaine use, especially long-term, is associated with an increased risk of all-cause mortality, and with several significant, life-threatening cardiovascular diseases although the multifactorial underlying cellular and molecular pathophysiological mechanisms of acute and chronic cocaine cardiotoxicity are not well established due to limited studies. Current findings have important public health implications, reinforcing recommendations for substance use screening among young adults with heart diseases, and highlighting the need for education on its deleterious effects. Cocaine should be considered a cardiovascular risk factor, requiring attention to early detection of vascular disease in cocaine users.

Identifiants

pubmed: 35674035
doi: 10.1714/3810.37941
doi:

Substances chimiques

Cocaine I5Y540LHVR

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

444-453

Auteurs

Francesco Ciccirillo (F)

U.O.C. Cardiologia, Ospedale Vito Fazzi, Lecce.

Maurizio Giuseppe Abrignani (MG)

U.O.C. Cardiologia, P.O. S. Antonio Abate, ASP Trapani.

Daniele Grosseto (D)

U.O. Cardiologia, Ospedale S. Giuseppe da Copertino, Copertino (LE).

Antonio Francesco Amico (AF)

U.O. Cardiologia, Ospedale Infermi, Rimini.

Sara Cocozza (S)

U.O. Cardiologia, A.O. G. Rummo, Benevento.

Michele Gabriele (M)

U.O. Cardiologia, Ospedale Abele Ajello, ASP Trapani.

Nuccia Morici (N)

U.O. Cardiologia, ASST Grande Ospedale Metropolitano Niguarda, Milano.

Andrea Santucci (A)

U.O. Cardiologia, A.O. di Perugia, Perugia.

Antonio Boschini (A)

Comunità San Patrignano.

Francesco Giallauria (F)

Divisione Medicina Interna ad Indirizzo Metabolico e Riabilitativo, Università di Napoli Federico II, Napoli.

Michele Massimo Gulizia (MM)

U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione "Garibaldi", Catania - Fondazione per il Tuo cuore - Heart Care Foundation, Firenze.

Domenico Gabrielli (D)

U.O.C. Cardiologia-UTIC, Azienda Ospedaliera San Camillo Forlanini, Roma.

Furio Colivicchi (F)

U.O.C. Cardiologia, P.O. San Filippo Neri, ASL Roma 1, Roma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH